Developer of a pipeline for psychedelic therapy intended to heal individual mental health and strengthen communities. The company's platform includes a portfolio of plant-identical compounds for the development of mescaline, a hallucinogenic compound for treating mental health-related problems, thereby enabling society, social groups, and minorities to heal their mental illness.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC (Series A1) | 01-Nov-2021 | $15.7M | 000.00 | 000.00 | Completed | Pre-Clinical Trials |
1. Accelerator/Incubator | 26-Oct-2020 | 000 | 000 | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A2 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series A1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series A | 1,754,488 | $0.000010 | $1.71 | $1.71 | 1x | $1.71 | 10.56% |
Name | Representing | Role | Since |
---|---|---|---|
Jeeshan Chowdhury Ph.D | Journey Colab | Founder, Chief Executive Officer & Board Member | 000 0000 |
Krishna Kantheti | Self | Board Member | 000 0000 |
Sam Altman | Apollo Project | Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Andrew Houston | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Delphi VC (New York) | Venture Capital | Minority | 000 0000 | 000000 0 | |
Lionheart Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
MBX Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Uprising | Venture Capital | Minority | 000 0000 | 000000 0 |